Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 917647, 12 pages
http://dx.doi.org/10.1155/2013/917647
Review Article

Diet and Nutrition in Cancer Survivorship and Palliative Care

1Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA
2Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong

Received 6 May 2013; Revised 7 September 2013; Accepted 18 September 2013

Academic Editor: Tuhinadri Sen

Copyright © 2013 Anthony J. Bazzan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Velentzis, M. R. Keshtgar, J. V. Woodside et al., “Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study,” Breast Cancer Research and Treatment, vol. 128, no. 2, pp. 473–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. W. Nixon, M. Kutner, S. Heymsfield et al., “Resting energy expenditure in lung and colon cancer,” Metabolism, vol. 37, no. 11, pp. 1059–1064, 1988. View at Publisher · View at Google Scholar · View at Scopus
  3. J. S. Falconer, K. C. H. Fearon, C. E. Plester, J. A. Ross, and D. C. Carter, “Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer,” Annals of Surgery, vol. 219, no. 4, pp. 325–331, 1994. View at Google Scholar · View at Scopus
  4. D. T. Dempsey, I. D. Feurer, and L. S. Knox, “Energy expenditure in malnourished gastrointestinal cancer patients,” Cancer, vol. 53, no. 6, pp. 1265–1273, 1984. View at Google Scholar
  5. C. Doyle, L. H. Kushi, T. Byers et al., “Nutrition and physical activity during and after cancer treatment: an American cancer society guide for informed choices,” CA Cancer Journal for Clinicians, vol. 56, no. 6, pp. 323–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Wallengren, I. Bosaeus, and K. Lundholm, “Dietary energy density is associated with energy intake in palliative care cancer patients,” Supportive Care in Cancer, vol. 20, no. 11, pp. 2851–2857, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Bruera, F. Strasser, J. L. Palmer et al., “Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study,” Journal of Clinical Oncology, vol. 21, no. 1, pp. 129–134, 2003. View at Google Scholar · View at Scopus
  8. M. Winkler, “Body compositional changes in cancer cachexia: are they reversible?” Topics in Clinical Nutrition, vol. 19, pp. 85–94, 2004. View at Google Scholar
  9. C. Deans and S. J. Wigmore, “Systemic inflammation, cachexia and prognosis in patients with cancer,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 8, no. 3, pp. 265–269, 2005. View at Google Scholar · View at Scopus
  10. G. Rockenbach, P. F. di Pietro, C. Ambrosi et al., “Dietary intake and oxidative stress in breast cancer: before and after treatments,” Nutrición Hospitalaria, vol. 26, no. 4, pp. 737–744, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. L. Kwan, E. Weltzien, L. H. Kushi, A. Castillo, M. L. Slattery, and B. J. Caan, “Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer,” Journal of Clinical Oncology, vol. 27, no. 6, pp. 919–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Villarini, p. Pasanisi, M. Raimondi et al., “Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study,” Breast Cancer Research and Treatment, vol. 135, no. 2, pp. 581–589, 2012. View at Publisher · View at Google Scholar
  13. W. Demark-Wahnefried, K. L. Campbell, and S. C. Hayes, “Weight management and its role in breast cancer rehabilitation,” Cancer, vol. 118, no. 8, pp. 2277–2287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. T. Mosby, M. Cosgrove, S. Sarkardei S, K. L. Platt, and B. Kaina, “Nutrition in adult and childhood cancer: role of carcinogens and anti-carcinogens,” Anticancer Research, vol. 32, no. 10, pp. 4171–4192, 2012. View at Google Scholar
  15. I. Drake, E. Sonestedt, B. Gullberg et al., “Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malmö diet and cancer cohort,” American Journal of Clinical Nutrition, vol. 96, no. 6, pp. 1409–1418, 2012. View at Publisher · View at Google Scholar
  16. H. Liu and A. P. Heaney, “Refined fructose and cancer,” Expert Opinion on Therapeutic Targets, vol. 15, no. 9, pp. 1049–1059, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Port, M. R. Ruth, and N. W. Istfan, “Fructose consumption and cancer: is there a connection?” Current Opinion in Endocrinology Diabetes and Obesity, vol. 19, no. 5, pp. 367–374, 2012. View at Publisher · View at Google Scholar
  18. D. H. Cohen and D. LeRoith, “Obesity, type 2 diabetes, and cancer: the insulin and IGF connection,” Endocrine Related Cancer, vol. 19, no. 5, pp. F27–F45, 2012. View at Publisher · View at Google Scholar
  19. E. J. Gallagher and D. LeRoith, “The proliferating role of insulin and insulin-like growth factors in cancer,” Trends in Endocrinology and Metabolism, vol. 21, no. 10, pp. 610–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. D. G. A. J. Hebels, K. M. Sveje, M. C. de Kok et al., “Red meat intake-induced increases in fecal water genotoxicity correlate with pro-carcinogenic gene expression changes in the human colon,” Food and Chemical Toxicology, vol. 50, no. 2, pp. 95–103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. F.-Y. Tang, M.-H. Pai, and E.-P. I. Chiang, “Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model,” Journal of Nutritional Biochemistry, vol. 23, no. 10, pp. 1302–1313, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. E. Corpet, “Red meat and colon cancer: should we become vegetarians, or can we make meat safer?” Meat Science, vol. 89, no. 3, pp. 310–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Meyerhardt, “Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventions,” Seminars in Oncology, vol. 38, no. 4, pp. 533–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Montonen, H. Boeing H, A. Fritsche et al., “Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress,” European Journal of Nutrition, vol. 52, no. 1, pp. 337–345, 2012. View at Google Scholar
  25. J. W. Wu, A. J. Cross, D. Baris et al., “Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States,” British Journal of Cancer, vol. 106, no. 11, pp. 1891–1898, 2012. View at Google Scholar
  26. G. Sethi, M. K. Shanmugam, L. Ramachandran, A. P. Kumar, and V. Tergaonkar, “Multifaceted link between cancer and inflammation,” Bioscience Reports, vol. 32, no. 1, pp. 1–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Nathan and A. Cunningham-Bussel, “Beyond oxidative stress: an immunologist's guide to reactive oxygen species,” Nature Reviews in Immunology, vol. 13, no. 5, pp. 349–361, 2013. View at Publisher · View at Google Scholar
  28. V. N. Sumantran and G. Tillu, “Cancer, inflammation, and insights from ayurveda,” Evidence Based Complementary and Alternative Medicine, vol. 2012, Article ID 306346, 11 pages, 2012. View at Publisher · View at Google Scholar
  29. M. F. McCarty, “mTORC1 activity as a determinant of cancer risk—rationalizing the cancer-preventive effects of adiponectin, metformin, rapamycin, and low-protein vegan diets,” Medical Hypotheses, vol. 77, no. 4, pp. 642–648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Fernández, B. De Las Heras, M. D. García, M. T. Sáenz, and A. Villar, “New insights into the mechanism of action of the anti-inflammatory triterpene lupeol,” Journal of Pharmacy and Pharmacology, vol. 53, no. 11, pp. 1533–1539, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. V. R. Yadav, S. Prasad, B. Sung, R. Kannappan, and B. B. Aggarwal, “Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer,” Toxins, vol. 2, no. 10, pp. 2428–2466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Gingras and R. Béliveau, “Colorectal cancer prevention through dietary and lifestyle modifications,” Cancer Microenvironment, vol. 4, no. 2, pp. 133–139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Tantamango-Bartley, K. Jaceldo-Siegl, J. Fan, and G. Fraser, “Vegetarian diets and the incidence of cancer in a low-risk population,” Cancer Epidemiology, Biomarkers & Prevention, vol. 22, no. 2, pp. 286–294, 2013. View at Google Scholar
  34. V. C. Haydé, G. G. Ramón, G. O. Lorenzo et al., “Non-digestible fraction of beans (Phaseolus vulgarisL.) modulates signalling pathway genes at an early stage of colon cancer in Sprague-Dawley rats,” British Journal of Nutrition, vol. 108, supplement 1, pp. S145–S154, 2012. View at Publisher · View at Google Scholar
  35. A. Pietro Femia, C. Luceri, F. Bianchini et al., “Marie Ménard apples with high polyphenol content and a low-fat diet reduce 1, 2-dimethylhydrazine-induced colon carcinogenesis in rats: effects on inflammation and apoptosis,” Molecular Nutrition Food Research, vol. 56, no. 8, pp. 1353–1357, 2012. View at Publisher · View at Google Scholar
  36. R. W. Knackstedt, V. R. Moseley, and M. J. Wargovich, “Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer,” Anticancer Agents in Medicinal Chemistry, vol. 12, no. 10, pp. 1203–1210, 2012. View at Publisher · View at Google Scholar
  37. U. Dougherty, R. Mustafi, Y. Wang et al., “American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR,” BMC Complementary and Alternative Medicine, vol. 11, article 111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. A. Monti and A. J. Bazzan, The Great Life Makeover, Collins Living, New York, NY, USA, 2008.
  39. S. Abd El-Atti, K. Wasicek, S. Mark, and R. Hegazi, “Use of probiotics in the management of chemotherapy-induced diarrhea: a case study,” Journal of Parenteral and Enteral Nutrition, vol. 33, no. 5, pp. 569–570, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Boleij and H. Tjalsma, “Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer,” Biological Reviews, vol. 87, no. 3, pp. 701–730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. de Moreno de LeBlanc, C. Matar, and G. Perdigón, “The application of probiotics in cancer,” British Journal of Nutrition, vol. 98, supplement 1, pp. S105–S110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Wanchai, J. M. Armer, and B. R. Stewart, “Complementary and alternative medicine use among women with breast cancer: a systematic review,” Clinical Journal of Oncology Nursing, vol. 14, no. 4, pp. E45–E55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J. A. Astin, C. Reilly, C. Perkins, and W. L. Child, “Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation,” Journal of the Society for Integrative Oncology, vol. 4, no. 4, pp. 157–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Jirillo, F. Jirillo, and T. Magrone, “Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune system,” International Journal of Vitamin Nutrition Research, vol. 82, no. 3, pp. 200–208, 2012. View at Publisher · View at Google Scholar
  45. R. M. Patel and P. W. Denning, “Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?” Clinical Perinatology, vol. 40, no. 1, pp. 11–25, 2013. View at Publisher · View at Google Scholar
  46. A. M. Gallimore and A. Godkin, “Epithelial barriers, microbiota, and colorectal cancer,” The New England Journal of Medicine, vol. 368, no. 3, pp. 282–284, 2013. View at Publisher · View at Google Scholar
  47. M. Kumar, R. Nagpal, V. Verma et al., “Probiotic metabolites as epigenetic targets in the prevention of colon cancer,” Nutrition Reviews, vol. 71, no. 1, pp. 23–34, 2013. View at Google Scholar
  48. A. Verma and G. Shukla, “Probiotics Lactobacillus rhamnosus GG, Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats,” Nutrition and Cancer, vol. 65, no. 1, pp. 84–91, 2013. View at Google Scholar
  49. F. . Di Bartolomeo, J. B. Startek, and W. Van den Ende, “Prebiotics to fight diseases: reality or fiction?” Phytotherapy Research, vol. 27, no. 10, pp. 1457–1473, 2012. View at Publisher · View at Google Scholar
  50. D. O. Otieno and B. K. Ahring BK, “The potential for oligosaccharide production from the hemicellulose fraction of biomasses through pretreatment processes: xylooligosaccharides (XOS), arabinooligosaccharides (AOS), and mannooligosaccharides (MOS),” Carbohydrate Research, vol. 360, pp. 84–92, 2012. View at Google Scholar
  51. G. C. Actis, S. Tarallo, and F. Rosina, “Cutting edge: chemoprevention of colorectal neoplasia in inflammatory bowel disease.,” Inflammation and Allergy Drug Targets, vol. 12, no. 1, pp. 1–7, 2012. View at Google Scholar
  52. J. Bassaganya-Riera, M. Viladomiu, M. Pedragosa, C. De Simone, and R. Hontecillas, “Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria,” PLoS One, vol. 7, no. 4, Article ID e34676, 2012. View at Publisher · View at Google Scholar
  53. A. Orlando and F. Russo, “Intestinal microbiota, probiotics and human gastrointestinal cancers,” Journal of Gastrointestinal Cancer, vol. 44, no. 2, pp. 121–131, 2013. View at Publisher · View at Google Scholar
  54. M. Uccello, G. Malaguarnera, F. Basile et al., “Potential role of probiotics on colorectal cancer prevention,” BMC Surgery, vol. 12, supplement 1, p. S35, 2012. View at Publisher · View at Google Scholar
  55. K. L. Visich and T. P. Yeo, “The prophylactic use of probiotics in the prevention of radiation therapy-induced diarrhea,” Clinical Journal of Oncology Nursing, vol. 14, no. 4, pp. 467–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Delia, G. Sansotta, V. Donato et al., “Use of probiotics for prevention of radiation-induced diarrhea,” World Journal of Gastroenterology, vol. 13, no. 6, pp. 912–915, 2007. View at Google Scholar · View at Scopus
  57. P. Delia, G. Sansotta, V. Donato et al., “Prophylaxis of diarrhoea in patients submitted to radiotherapeutic treatment on pelvic district: personal experience,” Digestive and Liver Disease, vol. 34, no. 2, pp. S84–S86, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. J. M. Bowen, A. M. Stringer, R. J. Gibson, A. S. J. Yeoh, S. Hannam, and D. M. K. Keefe, “VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss,” Cancer Biology and Therapy, vol. 6, no. 9, pp. 1449–1454, 2007. View at Google Scholar · View at Scopus
  59. P. Österlund, T. Ruotsalainen, R. Korpela et al., “Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study,” British Journal of Cancer, vol. 97, no. 8, pp. 1028–1034, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Aagaard, J. Petrosino, W. Keitel et al., “The human microbiome project strategy for comprehensive sampling of the human microbiome and why it matters,” FASEB Jounal, vol. 27, no. 3, pp. 1012–1022, 2012. View at Google Scholar
  61. S. Devaraj, P. Hemarajata, and J. Versalovic, “The human gut microbiome and body metabolism: implications for obesity and diabetes,” Clinical Chemistry, vol. 59, no. 4, pp. 617–628, 2013. View at Publisher · View at Google Scholar
  62. K. Peitsidou, T. Karantanos, and G. E. Theodoropoulos, “Probiotics, prebiotics, synbiotics: is there enough evidence to support their use in colorectal cancer surgery?” Digestive Surgery, vol. 29, no. 5, pp. 426–438, 2012. View at Publisher · View at Google Scholar
  63. B. C. Johnston, S. S. Ma, J. Z. Goldenberg et al., “Probiotics for the prevention of clostridium difficile-associated diarrhea: a systematic review and meta-analysis,” Annals of Internal Medicine, vol. 157, no. 12, pp. 878–888, 2012. View at Publisher · View at Google Scholar
  64. R. J. Boyle, R. M. Robins-Browne, and M. L. K. Tang, “Probiotic use in clinical practice: what are the risks?” American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1256–1264, 2006. View at Google Scholar · View at Scopus
  65. J. P. Vanden Heuvel, “Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids,” Progress in Molecular Biology and Translational Science, vol. 108, pp. 75–112, 2012. View at Google Scholar
  66. M. A. Hull, “Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasia,” Recent Results in Cancer Research, vol. 191, pp. 143–156, 2013. View at Publisher · View at Google Scholar
  67. N. Habermann, C. M. Ulrich, A. Lundgreen et al., “PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer,” Genes and Nutrition, vol. 8, no. 1, pp. 115–126, 2013. View at Publisher · View at Google Scholar
  68. P. Yang, C. Cartwright, D. Chan et al., “Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE(2) and PGE(3) and Alteration of Akt Phosphorylation,” Molecular Carcinogenesis, 2013. View at Publisher · View at Google Scholar
  69. C. M. Alfano, I. Imayama, M. L. Neuhouser et al., “Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors,” Journal of Clinical Oncology, vol. 30, no. 12, pp. 1280–1287, 2012. View at Publisher · View at Google Scholar
  70. D. Rovito, C. Giordano, D. Vizza et al., “Omega-3 PUFA ethanolamines DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells,” Journal of Cellular Physiology, vol. 228, no. 6, pp. 1314–1322, 2012. View at Google Scholar
  71. P. Bougnoux, N. Hajjaji, K. Maheo, C. Couet, and S. Chevalier, “Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth,” Progress in Lipid Research, vol. 49, no. 1, pp. 76–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. J.-Y. Kim, H. D. Park, E. Park, J.-W. Chon, and Y. K. Park, “Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells: second look at n-3 fatty acid,” Annals of the New York Academy of Sciences, vol. 1171, pp. 190–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. W. Jiang, Z. Zhu, J. N. McGinley, K. El Bayoumy, A. Manni, and H. J. Thompson, “Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids,” Cancer Research, vol. 72, no. 15, pp. 3795–3806, 2012. View at Publisher · View at Google Scholar
  74. H. Zhang, L. Zhou, W. Shi, N. Song, K. Yu, and Y. Gu, “A mechanism underlying the effects of polyunsaturated fatty acids on breast cancer,” International Journal of Molecular Medicine, vol. 30, no. 3, pp. 487–494, 2012. View at Google Scholar
  75. A. Xiong, W. Yu, R. Tiwary, B. G. Sanders, and K. Kline, “Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells,” Molecular Nutrition and Food Research, vol. 56, no. 6, pp. 923–934, 2012. View at Google Scholar
  76. C. C. Mandal, T. Ghosh-Choudhury, N. Dey, G. G. Choudhury, and N. Ghosh-Choudhury, “miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression,” Carcinogenesis, vol. 33, no. 10, pp. 1897–1908, 2012. View at Google Scholar
  77. H. Arem, M. L. Neuhouser, M. L. Irwin ML et al., “Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case-control study,” European Journal of Nutrition, vol. 52, no. 3, pp. 1251–1260, 2012. View at Google Scholar
  78. M. Fukui, K. S. Kang, K. Okada, and B. T. Zhu BT, “EPA, an omega-3 fatty acid, induces apoptosis in human pancreatic cancer cells: role of ROS accumulation, caspase-8 activation, and autophagy induction,” Journal of Cellular Biochemistry, vol. 114, no. 1, pp. 192–203, 2013. View at Google Scholar
  79. M. M. Epstein, J. L. Kasperzyk, L. A. Mucci et al., “Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden,” American Journal of Epidemiology, vol. 176, no. 3, pp. 240–252, 2012. View at Google Scholar
  80. Z. Ghoreishi, A. Esfahani, A. Djazayeri et al., “Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial,” BMC Cancer, vol. 12, p. 355, 2012. View at Publisher · View at Google Scholar
  81. H. Long, H. Yang, Y. Lin, D. Situ, and W. Liu, “Fish oil-supplemented parenteral nutrition in patients following esophageal cancer surgery: effect on inflammation and immune function,” Nutrition and Cancer, vol. 65, no. 1, pp. 71–75, 2013. View at Google Scholar
  82. T. C. Chen, T. Sakaki, K. Yamamoto, and A. Kittaka, “The roles of cytochrome P450 enzymes in prostate cancer development and treatment,” Anticancer Research, vol. 32, no. 1, pp. 291–298, 2012. View at Google Scholar · View at Scopus
  83. S. L. Hines, H. K. S. Jorn, K. M. Thompson, and J. M. Larson, “Breast cancer survivors and vitamin D: a review,” Nutrition, vol. 26, no. 3, pp. 255–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. K.-C. Chiang, C.-N. Yeh, M.-F. Chen, and T. C. Chen, “Hepatocellular carcinoma and vitamin D: a review,” Journal of Gastroenterology and Hepatology, vol. 26, no. 11, pp. 1597–1603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. K.-C. Chiang, C.-N. Yeh, and T. C. Chen, “Vitamin D and pancreatic cancer-an update,” Cancers, vol. 3, no. 1, pp. 213–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. T. M. Churilla, H. D. Brereton, M. Klem, and C. A. Peters, “Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience,” Nutrition Cancer, vol. 64, no. 4, pp. 521–525, 2012. View at Publisher · View at Google Scholar
  87. C. F. Friedman, A. DeMichele, H. I. Su et al., “Vitamin D deficiency in postmenopausal breast cancer survivors,” Journal of Women's Health, vol. 21, no. 4, pp. 456–462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Tretli, G. G. Schwartz, P. A. Torjesen, and T. E. Robsahm, “Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study,” Cancer Causes and Control, vol. 23, no. 2, pp. 363–370, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Y. Cheng and M. L. Neuhouser, “Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction,” Cancer Causes and Control, vol. 23, no. 9, pp. 1557–1565, 2012. View at Publisher · View at Google Scholar
  90. M. Walentowicz-Sadlecka, M. Grabiec, and P. Sadlecki P, “25(OH)D3 in patients with ovarian cancer and its correlation with survival,” Clinical Biochemistry, vol. 45, no. 18, pp. 1568–1572, 2012. View at Google Scholar
  91. S. Hatse, D. Lambrechts, A. Verstuyf et al., “Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency,” Carcinogenesis, vol. 33, no. 7, pp. 1319–1326, 2012. View at Publisher · View at Google Scholar
  92. D. Trivanovic, S. Plestina, R. Dobrilla-Dintinjana et al., “Vitamin D3 supplementation to improve fatigue in patients with advanced cancer,” Journal of Clinical Oncology, vol. 30, Proceedings of the ASCO Annual Meeting, abstract no. 9097, no. 15, supplement, 2012. View at Google Scholar
  93. D. T. Marshall, S. J. Savage, E. Garrett-Mayer E et al., “Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 7, pp. 2315–2324, 2012. View at Google Scholar
  94. A. L. Rastelli, M. E. Taylor, F. Gao et al., “Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial,” Breast Cancer Research and Treatment, vol. 129, no. 1, pp. 107–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. M. L. Kwan, H. Greenlee, V. S. Lee et al., “Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the life after cancer epidemiology study,” Breast Cancer Research and Treatment, vol. 130, no. 1, pp. 195–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. K. I. Block, A. C. Koch, M. N. Mead, P. K. Tothy, R. A. Newman, and C. Gyllenhaal, “Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials,” Cancer Treatment Reviews, vol. 33, no. 5, pp. 407–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. M. W. Epperly, H. Wang, J. A. Jones, T. Dixon, C. A. Montesinos, and J. S. Greenberger, “Antioxidant-chemoprevention diet ameliorates late effects of total-body irradiation and supplements radioprotection by MnSOD-plasmid liposome administration,” Radiation Research, vol. 175, no. 6, pp. 759–765, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. S. C. Forester and J. D. Lambert, “The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention,” Molecular Nutrition and Food Research, vol. 55, no. 6, pp. 844–854, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Chen, V. Milacic, M. S. Chen et al., “Tea polyphenols, their biological effects and potential molecular targets,” Histology and Histopathology, vol. 23, no. 4–6, pp. 487–496, 2008. View at Google Scholar · View at Scopus
  100. I. S. Santos, B. M. Ponte, P. Boonme, A. M. Silva, and E. B. Souto, “Nanoencapsulation of polyphenols for protective effect against colon-rectal cancer,” Biotechnology Advances, vol. 31, no. 5, pp. 514–523, 2012. View at Publisher · View at Google Scholar
  101. N. Darmon, M. Darmon, M. Maillot, and A. Drewnowski, “A nutrient density standard for vegetables and fruits: nutrients per calorie and nutrients per unit cost,” Journal of the American Dietetic Association, vol. 105, no. 12, pp. 1881–1887, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. C. T. McEvoy, N. Temple, and J. V. Woodside, “Vegetarian diets, low-meat diets and health: a review,” Public Health and Nutrition, vol. 15, no. 12, pp. 2287–2294, 2012. View at Google Scholar
  103. T. Huang, B. Yang, J. Zheng, G. Li, M. L. Wahlqvist, and D. Li, “Cardiovascular disease mortality and cancer incidence in vegetarians: a meta-analysis and systematic review,” Annals of Nutrition and Metabolism, vol. 60, no. 4, pp. 233–240, 2012. View at Google Scholar